📰 Sustained Efficacy News
Sustained Efficacy News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sustained Efficacy. Real-time updates on events, politics, business and more.
May 23, 2023
DEVON, Pa., May 23, 2023 -- Zynerba Pharmaceuticals, Inc. , the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today... | May 23, 2023
April 13, 2023
Zygel continued to be well-tolerated with long-term administration and maintained clinically meaningful improvements in children and adolescents with Fragile X syndrome Zygel achieved statistically... | April 13, 2023
April 12, 2023
Zygel continued to be well-tolerated with long-term administration and maintained clinically meaningful improvements in children and adolescents with Fragile X syndrome Zygel achieved statistically... | April 12, 2023
April 12, 2023
12.04.2023 - Zygel continued to be well-tolerated with long-term administration and maintained clinically meaningful improvements in children and adolescents with Fragile X syndrome Zygel achieved statistically significant and clinically meaningful improvements ... Seite 1
April 5, 2023
DEVON, Pa., April 05, 2023 -- Zynerba Pharmaceuticals, Inc. , the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today... | April 5, 2023
October 18, 2022
- New Clinical and Patient-Reported Outcomes in People with HIV on Biktarvy in Observational BICSTaR Study Demonstrate Consistent Efficacy Profile in Real-World Setting - - Long-Term Switch Data
July 7, 2022
Lobe Sciences Ltd has announced the development of its initial Phase 1 study plan to demonstrate the safety and appropriate dosing range for its proprietary...
July 7, 2022
Lobe Sciences Ltd has announced the development of its initial Phase 1 study plan to demonstrate the safety and appropriate dosing range for its proprietary...
July 7, 2022
Lobe Sciences Ltd has announced the development of its initial Phase 1 study plan to demonstrate the safety and appropriate dosing range for its proprietary...
June 1, 2022
Zynerba Pharmaceuticals (NASDAQ:ZYNE) Inc has said it will deliver oral and poster presentations on its CBD gel Zygel at the American Society of Clinical...